Related Experiment Video
Updated: May 29, 2026
06:09
Adult and Pediatric Porcine Model of Acute Volume Overload
Published on: January 12, 2024
Differences between adult and pediatric septic shock.
1Departments of Critical Care Medicine and Pediatrics, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, PA, USA. anejar@upmc.edu
Minerva Anestesiologica
|September 29, 2011
Summary
Pediatric and adult septic shock share similarities but differ in pathophysiology and treatment. This review highlights key distinctions in hemodynamic response, Activated Protein C, thrombocytopenia, and Hemophagocytic Lymphohistiocytosis (HLH).
Area of Science:
- Pediatric critical care medicine
- Immunology
- Hematology
Background:
- Sepsis is a life-threatening condition impacting both children and adults.
- Septic shock management shows similarities between pediatric and adult patients.
- Crucial differences exist in pathophysiology, clinical presentation, and treatment strategies.
Purpose of the Study:
- To delineate the key distinctions between pediatric and adult septic shock.
- To provide a comprehensive review of age-specific differences in sepsis management.
- To highlight areas for targeted research and therapeutic development.
Main Methods:
- Review of existing literature on pediatric and adult sepsis.
- Comparative analysis of pathophysiological mechanisms.
- Discussion of clinical presentation and therapeutic approaches.
Main Results:
- Significant developmental differences in hemodynamic responses observed in pediatric sepsis.
- Variations in the role and efficacy of Activated Protein C (APC) between age groups.
- Distinct patterns of thrombocytopenia-associated multiple organ failure.
- Unique considerations for Hemophagocytic Lymphohistiocytosis (HLH) in pediatric sepsis.
Conclusions:
- Understanding age-specific differences is critical for effective sepsis management.
- Therapeutic strategies for pediatric septic shock require tailored approaches.
- Further research into developmental aspects of sepsis pathophysiology is warranted.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...